LGC

LGC, also known as the LGC Group, is a leading company that specializes in providing innovative solutions across various industries. With a focus on viral epidemics and pandemics, LGC assists assay developers and clinical labs in responding to outbreaks such as coronavirus, Ebola, and Zika. Their AccuPlex recombinant viral materials are not only safe to handle but also non-infectious, closely resembling complex clinical virus targets. This makes them an essential tool in the development of effective solutions to combat infectious disease epidemics like COVID-19. LGC's expertise extends beyond viral outbreaks to cancer screening. They supply critical components that support translational research aimed at solving the challenges of cancer. Scientists worldwide seek out LGC's manufacturing capabilities in novel enzymes and oligonucleotides, as these components aid in research, diagnostics development, and disease treatment. The company's commitment to innovation also encompasses nucleic acid therapies. LGC empowers healthcare professionals to develop new therapies that significantly enhance the quality of life for patients through their nucleic acid chemistry capabilities. Their oligo components, probes, and primers enable the detection and development of vaccines for illnesses like COVID-19, contributing to the advancement of medical science. Additionally, LGC is dedicated to improving farming productivity. They collaborate with agricultural biotechnology companies to address the productivity challenge at the core of the global food supply problem. Their comprehensive range of products and services help accelerate breeding decisions in an efficient and cost-effective manner, including the identification of new plant varieties. By enhancing farming productivity, LGC plays a vital role in ensuring a sustainable and secure food supply for the growing global population. Overall, LGC is a dynamic company at the forefront of innovation, working across various sectors to provide solutions that positively impact the world. Their expertise in viral epidemics, cancer screening, nucleic acid therapies, and farming productivity positions them as an invaluable partner for clients seeking cutting-edge solutions to complex challenges.